M&A Group Of The Year: Sullivan & Cromwell
Sullivan & Cromwell LLP's global team steered acquisitions, divestitures and spin-offs for a diverse mix of clients over the past year, highlighted by migraine-treatment developer Biohaven Pharmaceuticals Inc.'s $11.6 billion sale...To view the full article, register now.
Already a subscriber? Click here to view full article